DR REDDYS LABORATORIES
|
The Current P/E Ratio of DR REDDYS LABORATORIES is 18.73.
Share Price | ₹1,214.0 | Nov 19,2024 |
Market Cap | ₹101,292.0 Cr | |
Earnings-TTM | ₹5,406.8 Cr | TTM-Consolidated Results |
Price/Earnings | 18.73x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of DR REDDYS LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹101,292.0 Cr] as on Nov 19,2024
(/) Earnings [ ₹5,406.8 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 18.73x ]
Thus, for DR REDDYS LABORATORIES , the investors are currently willing to pay 18.73 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of DR REDDYS LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of DR REDDYS LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of DR REDDYS LABORATORIES
PE Ratio Performance Analysis for DR REDDYS LABORATORIES
- DR REDDYS LABORATORIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 26.48x.
- DR REDDYS LABORATORIES 's operated at median p/e ratio of 25.57x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, DR REDDYS LABORATORIES 's p/e ratio peaked in Mar2021 at 38.5x.
- DR REDDYS LABORATORIES 's p/e ratio hit its five-year low in Mar2023 of 17.08x.
How does DR REDDYS LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
DR REDDYS LABORATORIES | 5,406.80 | 18.73 | 101,292.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,136.50 | 38.25 | 425,930.0 |
CIPLA LTD | 4,485.22 | 26.49 | 118,828.0 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 22.16 | 95,280.3 |
DIVIS LABORATORIES LTD | 1,836.00 | 85.25 | 156,524.0 |
MANKIND PHARMA LTD | 2,124.86 | 48.42 | 102,890.0 |
TORRENT PHARMACEUTICALS LTD | 1,802.00 | 58.13 | 104,742.0 |
LUPIN LTD | 2,651.94 | 35.04 | 92,929.7 |
AUROBINDO PHARMA LTD | 3,598.83 | 20.14 | 72,478.2 |
ABBOTT INDIA LTD | 1,284.66 | 44.98 | 57,784.9 |
ALKEM LABORATORIES LTD | 2,160.96 | 30.57 | 66,062.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs DR REDDYS LABORATORIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.73x |
Max industry PE | 85.25x |
Median industry PE | 35.04x |
Average industry PE | 38.92x |
You may also like the below Video Courses